ATF-2 activators encompass a range of compounds that indirectly enhance the functional activity of ATF-2, a transcription factor involved in various cellular processes. These activators primarily function by modulating signaling pathways that lead to the phosphorylation and activation of ATF-2. Key pathways include the MAPK/ERK and JNK pathways, where ATF-2 is phosphorylated in response to various stimuli, enhancing its transcriptional activity. Compounds that activate these pathways, either directly or through upstream effectors, can lead to increased ATF-2 activity. This activation process is crucial for ATF-2's role in regulating genes involved in stress response, development, and cell proliferation.
In addition to direct activation of kinase pathways, some ATF-2 activators work by inhibiting competing pathways or enzymes, leading to compensatory cellular responses that activate ATF-2. For example, inhibitors of p38 MAPK or PI3K can result in the activation of alternative signaling routes that ultimately enhance ATF-2 activity. Similarly, the modulation of cellular cAMP levels, as seen with compounds like Forskolin and Caffeine, can influence PKA activity, which is another kinase known to phosphorylate and activate ATF-2. These varied mechanisms of action highlight the complex regulation of ATF-2 activity and underscore the potential of these activators in influencing ATF-2's role in cellular signaling and gene expression. By targeting various components of signaling pathways associated with ATF-2, these activators provide insights into the modulation of transcription factor activity and its implications in cellular functions
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates JNK, leading to the phosphorylation and activation of ATF-2. This can enhance ATF-2’s role in stress-responsive gene expression. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin increases cAMP levels, which can activate PKA. PKA phosphorylates ATF-2, potentially enhancing its transcriptional activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates the MAPK pathway, including JNK and ERK, which can lead to ATF-2 phosphorylation and activation, enhancing its transcriptional activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 inhibits MEK, a kinase upstream of ERK. Its inhibition can lead to altered signaling, potentially enhancing ATF-2 activity through compensatory mechanisms. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3K inhibitor, can influence various signaling pathways. This may lead to indirect ATF-2 activation through compensatory signaling mechanisms. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an MEK inhibitor that may lead to the activation of ATF-2 through alternative signaling pathways as a compensatory response. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, affecting several signaling pathways. This inhibition could indirectly activate ATF-2 through altered cellular signaling. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A is a PKC inhibitor. Inhibiting PKC can lead to changes in signaling cascades, potentially enhancing ATF-2 activity. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Caffeine, a known PKA activator, could enhance ATF-2 activity by increasing PKA-mediated phosphorylation of ATF-2. | ||||||